Carcinogenesis, Teratogenesis & Mutagenesis (CTM) is the official Journal of Chinese Environmental Mutagen Society and is undertaken by Shantou University Medical College. It is the source journal for Chinese Scientific and Technical Papers and Citations. The impact factor is 0.379 and ranks fourth among more than 30 Chinese oncologic journals according to Chinese S&T Journal Citation Reports 2003.
It may be worth mentioning that the Journal has been included in 14 Chinese important indexing systems, including CSTPC, CEPS, CJFD, CMCC, CBMDISC, CAJ-CD and so on.
Editorial board of CTM deeply appreciated what you have done for us and looks forward to your further attention and contribution.

  Carcinogenesis, Teratogenesis & Mutagenesis
Honorary Editor-in-Chief:
TAN Jia-zhen
Editor-in-Chief: CHENG Shu-jun
Deputy Editor-in-Chief:
HUANG Tian-hua (Executor) LI Yong LU You-yong WU Yi-min
Director of Editorial Office: HUANG Tian-hua
Editing: Editorial Board of Carcinogenesis, Teratogenesis & Mutagenesis 22 Xinling Road, Shantou, Guangdong, China 515041,
Tel & Fax: 0754-8900267,E-mail:cemsctm@stu.edu.cn
Publishing: Science Press
Distributor: Beijing Post Office in China
Domestic: All Local Post Office in China, Code No. 80-285, Unit price ¥6.00
Overseas Distributor: China International Book Trading Corporation (P.O. Box 399, Beijing 100044, China Code No. 6364 BM), Unit price: USD & 2.00
Printing: Jingmei Color Printing Co., Ltd

 
 
 

Carcinogenesis, Teratogenesis & Mutagenesis
The forth Editorial Board

 

Ruan Di-Yun
 

  Is a professor of School of Life Science, University of Science and Technology of China and a director of Neurotoxicology Lab. He is a supervisor of Chinese Committing of prevention lead poisoning for children and president of Society for Neuroscience in Anhui province. He is a member of the Chinese Society of Biophysics and Toxicology, Society for Neuroscience in USA, Organization of the International Brain Research and the International Toxicology. He is one of the editor for Chinese Journal of Pharmacology and Toxicology and a referee for Journal of Brain Research and Neuroscience. He graduated in Department of Biophysics, University of Science and Technology of China in 1965 and is still working in this university. As a visiting scholar, he worked in University of Houston, USA (1985-1989) and University of Montreal, Canada (1993-1994, 1998, 2000, 2001 and 2004). The publications of his books are Neurophysiology, Neurobiology, principle of Biology and the questions of Childhood Lead Poison. He has been first or coauthor of more than 60 scientific papers, most of them (46 papers) in international journals including Neurology, Brain Research., Neuroscience, Toxicology & Teratology, Pharmacology and Toxicology. His research areas are Neurobiology and Neurotoxicology, particularly the effects of chemical agents and environmental pollutants (Pb and Al) on the nervous system and behavior of humans and animals, and cellular and molecular mechanisms of these effects. His research projects are sponsored by National Basic Research Program (973 program), Academia Sinica, National Natural Science Foundation of China and Research Found for Doctoral Program of Higher Education. He has scientifically collaborated with some labs in Canada, Italy, Germen, USA and Hong Kong.. He was awarded prizes of the Academia Sinica and Anhui province for Science and Technology(1979) and excellence scientific research papers of Anhui province.

 
 
 
  Cheng Shujun is currently as a professor of Cancer Institute (Hospital), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, and Chief Scientist of both China State Key Basic Research Project “Fundamental investigation of human carcinogenesis and cancer therapy and prevention” and Beijing key Cancer Research Project “Tumor biomarker profiling and human cancer diagnosis and therapy”. He worked as a visiting scientist in Laboratoire de Medicine Experimental, Institute de la Recherches Scientifiques sur le Cancer, France (1978-1981), and in Department of Pathology, Medical College of Ohio, USA (1986-1987). He has established a series of short-term tests for the detection of environmental carcinogens and anti-carcinogens in China. He was elected as a Member, Chinese Academy of Engineering in 1999. Dr. Cheng is the President of Chinese Environmental Mutagen Society, and Vice President of China Anticancer Association. He found that the tea catechins showed a significant inhibitory effect against human genital condylomas and inflammatory hyperplasia. Based on the invention, he and his collaborators had received international patents “Composition for treating condyloma acuminate” in 1998. This invention had been approved to go for clinical phase III trial by US FDA. As invited speakers, Dr. Cheng has visited many institutes at foreign countries and attended at international conferences.
 
Please use 1024×768
Copyright
© 2005 editorial office of Carcinogenesis, Teratogenesis & Mutagenesis (CTM)
Address:22 Xin-Ling Road,Shantou,Guangdong,China (515041)
Tel & Fax:0754-8900267,E-mail:cemsctm@stu.edu.cn
Support by Beijing Magtech Co.ltd